Teva Pharmaceutical Industries (TEVA) Tax Rate Growth (1y) (2010 - 2026)

Teva Pharmaceutical Industries (TEVA) Tax Rate Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.42 Bn 87.55 Bn -
2 Teva Pharmaceutical Industries 35.89 Bn 32.15 Bn 1.97 Bn
3 Zoetis 32.44 Bn 30.50 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.55 Bn 23.49 Bn 4.39 Bn
5 United Therapeutics 23.13 Bn 20.98 Bn 648.10 Mn
6 RedHill Biopharma 21.17 Bn 21.17 Bn -
7 Viatris 20.33 Bn 18.53 Bn 1.16 Bn
8 Neurocrine Biosciences 17.77 Bn 16.45 Bn 800.70 Mn
9 Elanco Animal Health 12.63 Bn 12.20 Bn 785.00 Mn
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -984.00
Dec 31, 2025 -47,616.00
Sep 30, 2025 5,442.00
Jun 30, 2025 21,767.00
Mar 31, 2025 3,630.00
Dec 31, 2024 -900.00
Sep 30, 2024 -255.00
Jun 30, 2024 -25,783.00
Mar 31, 2024 -1,812.00
Dec 31, 2023 1,024.00
Sep 30, 2023 -8,132.00
Jun 30, 2023 -7,467.00
Mar 31, 2023 719.00
Dec 31, 2022 -2,629.00
Sep 30, 2022 4,268.00
Jun 30, 2022 4,458.00
Mar 31, 2022 -4,326.00
Dec 31, 2021 2,904.00
Sep 30, 2021 2,025.00
Jun 30, 2021 -17,210.00